Hyperlipidemia, Hypertriglyceridemia, Increased adipose tissue around the neck, Increased intraabdominal fat, Insulin resistance, Insulin-resistant diabetes mellitus, Lipodystrophy, Loss of gluteal subcutaneous adipose tissue, Loss of subcutaneous adipose tissue in limbs, Marked muscular hypertrophy, Muscular dystrophy, Oligomenorrhea, Polycystic ovaries, Proximal muscle weakness, Proximal muscle weakness in lower limbs, Proximal muscle weakness in upper limbs

abnormal hepatic glucose production, abnormal insulin secretion, abnormal lipid homeostasis, abnormal lipid level, abnormal lipolysis, abnormal pancreatic beta cell morphology, abnormal seminiferous tubule epithelium morphology, abnormal spermatid morphology, abnormal spermiogenesis, abnormal triglyceride level, abnormal white adipose tissue morphology, abnormal white adipose tissue physiology, abnormal white fat cell morphology, asthenozoospermia, decreased circulating adiponectin level, decreased circulating free fatty acids level, decreased circulating glycerol level, decreased lean body mass, decreased liver triglyceride level, decreased male germ cell number, decreased muscle cell glucose uptake, decreased skeletal muscle glycogen level, decreased susceptibility to diet-induced obesity, decreased testis weight, decreased triglyceride level, decreased white adipose tissue amount, growth/size/body region phenotype, increased brain weight, increased brown adipose tissue amount, increased circulating glucose level, increased food intake, increased lean body mass, increased oxygen consumption, increased pancreatic beta cell mass, increased percent body fat/body weight, increased triglyceride level, pancreatic islet hyperplasia, reduced male fertility